| |
|
|
| Monday May 12, 2008 |
|
| |
| Prohost is ranked #1 from among 355 publications. |
| Some of our topics include: |
Stem Cells
Genomics
Biotech industry news
Nanotechnology
FDA Approvals
Stock Performance
Breakthroughs in science.
M&As
Clinical trials - phase by phase.
...and much more |
|
|
|
|
| ABOUT PROHOST |
| The enormous advancement in the biological sciences that is taking place has begun to change the traditional way of practicing medicine. Far-reaching biological products are being approved and news about breakthroughs are occupying the headlines. However, selecting the biotechnology firms in which to invest requires not only an understanding of the company's finances, but also a knowledge of the company's potential and the potential and scientific validity of it's products and technologies. |
| Our Mission |
| Prohost evaluates biotechnology companies, their products and technologies, their scientists and managers, as well as their finances. Our goal is to impart our readers with the knowledge and insight so that they may have a heightened understanding and appreciation for the biotechnology industry. We hope this newfound insight can help our readers identify the newest blockbuster technologies and discover the next industry leaders. |
| Company Profile |
| Prohost is the premier biotechnology newsletter. In printed form, The Prohost Biotechnology Newsletter has been in circulation since 1992. Our readers are comprised of fund managers, investors, medical professionals and all kinds of individuals with one common interest, biotechnology. |
| Prohost publishes a monthly Newsletter and a weekly Faxletter. Both the Newsletter and the Faxletter are posted on the web in the Members' Area. Besides being available on the web, the Newsletter (12 pages) is mailed to all the subscribers. The Faxletter is also dispatched by fax or e-mail. Subscription to the Faxletter includes the Newsletter. |
| Prohost is ranked #1 from among 355 publications by an independent accounting firm hired by Select Information Exchange (SIE). Newsletters were rated based on their performances over the two year period of 1999 and 2000. |
| Contact Information |
Telephone
1-516-678-1335
1-866-4-PROBODY
FAX 1-718-423-2731 Email contact@prohostbiotech.com |
|
| |
|
|
|
| Home | Blog | Stocks | News and Comments | Subscribe now | About Us | Login |
| |
